Fuso Pharmaceutical Industries,Ltd. Logo

Fuso Pharmaceutical Industries,Ltd.

Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.

4538 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町一丁目7番10号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Fuso Pharmaceutical Industries, Ltd. is a manufacturer and seller of pharmaceuticals and medical equipment. Established in 1950, the company specializes in essential medical products, with a core portfolio centered on dialysis-related drugs, infusions, injections, and transfusion fluids. Fuso is actively involved in the research and development of new medicines, maintaining a pipeline of drugs in various clinical trial stages. The company's operations are guided by its mission of "Supporting Life, Nurturing Life," providing critical healthcare solutions to medical institutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Fuso Pharmaceutical Industries,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-26 04:32
Regulatory News Service
臨時報告書
Japanese 27.4 KB
2025-06-24 08:02
Regulatory News Service
内部統制報告書-第102期(2024/04/01-2025/03/31)
Japanese 25.2 KB
2025-06-24 08:01
Regulatory News Service
確認書
Japanese 9.4 KB
2025-06-24 08:00
Annual Report
有価証券報告書-第102期(2024/04/01-2025/03/31)
Japanese 1.0 MB
2025-06-03 10:03
Regulatory News Service
臨時報告書
Japanese 22.6 KB
2025-05-28 09:44
Regulatory News Service
臨時報告書
Japanese 23.6 KB
2024-11-12 07:02
Regulatory News Service
確認書
Japanese 9.3 KB
2024-11-12 07:01
Interim Report
半期報告書-第102期(2024/04/01-2025/03/31)
Japanese 189.2 KB
2024-06-26 03:18
Regulatory News Service
臨時報告書
Japanese 24.7 KB
2024-06-25 09:19
Regulatory News Service
内部統制報告書-第101期(2023/04/01-2024/03/31)
Japanese 24.1 KB
2024-06-25 09:17
Regulatory News Service
確認書
Japanese 9.4 KB
2024-06-25 09:04
Annual Report
有価証券報告書-第101期(2023/04/01-2024/03/31)
Japanese 1019.3 KB
2024-05-13 10:14
Regulatory News Service
臨時報告書
Japanese 23.1 KB
2024-03-27 09:07
Regulatory News Service
臨時報告書
Japanese 23.9 KB
2024-02-13 06:18
Regulatory News Service
訂正有価証券届出書(組込方式)
Japanese 173.2 KB

Automate Your Workflow. Get a real-time feed of all Fuso Pharmaceutical Industries,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fuso Pharmaceutical Industries,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel PMCN-M
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France ALPHE
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy PHIL
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy PRL
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Psych Capital Plc Logo
A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.
United Kingdom PSY
Pure Biologics S.A. Logo
Develops novel antibody & aptamer drugs for immuno-oncology and autoimmune diseases.
Poland PUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.